![Thomas Andrew Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Andrew Davis
Nessuna posizione attualmente
Storia della carriera di Thomas Andrew Davis
Precedenti posizioni note di Thomas Andrew Davis
Società | Posizione | Inizio | Fine |
---|---|---|---|
GENOCEA BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2018 | 20/05/2022 |
Gadeta BV
![]() Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Direttore Tecnico/Scientifico/R&S | 01/10/2017 | 01/04/2018 |
CELLDEX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 12/11/2009 | 01/09/2017 |
AVANT Immunotherapeutics, Inc.
![]() AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Direttore Tecnico/Scientifico/R&S | 07/03/2008 | 01/10/2008 |
Celldex Research Corp.
![]() Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Celldex Research Corp. engages in provision of biological research and development. The company is headquartered in Phillipsburg, NJ. | Direttore Tecnico/Scientifico/R&S | 01/04/2006 | 01/03/2008 |
GENVEC INC | Direttore Tecnico/Scientifico/R&S | 01/07/2005 | - |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Corporate Officer/Principal | 01/01/2001 | 01/06/2003 |
Formazione di Thomas Andrew Davis
Georgetown University | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Paesi Bassi | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 6 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Commercial Services | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
CELLDEX THERAPEUTICS, INC. | Health Services |
GENOCEA BIOSCIENCES, INC. | Health Technology |
Aziende private | 5 |
---|---|
AVANT Immunotherapeutics, Inc.
![]() AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | Health Technology |
GenVec, Inc.
![]() GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Celldex Research Corp.
![]() Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Celldex Research Corp. engages in provision of biological research and development. The company is headquartered in Phillipsburg, NJ. | Commercial Services |
Gadeta BV
![]() Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Thomas Andrew Davis
- Esperienza